Uptake of lipiodol-cytotoxics conjugates by hepatocellular carcinoma cells.
D006528:Carcinoma, Hepatocellular / Q000473:pathology*; D045744:Cell Line, Tumor / Q000187:drug effects / Q000378:metabolism; D002478:Cells, Cultured / Q000187:drug effects / Q000378:metabolism; D003593:Cytoplasm / Q000737:chemistry; D004317:Doxorubicin / Q000008:administration & dosage* / Q000494:pharmacology; D004337:Drug Carriers / Q000008:administration & dosage; D004354:Drug Screening Assays, Antitumor; D015251:Epirubicin / Q000008:administration & dosage* / Q000494:pharmacology; D022781:Hepatocytes / Q000187:drug effects* / Q000378:metabolism; D006801:Humans; D007459:Iodized Oil / Q000008:administration & dosage*; D008113:Liver Neoplasms / Q000473:pathology*; D018613:Microscopy, Confocal; D008854:Microscopy, Electron; D008856:Microscopy, Fluorescence; D014410:Tumor Stem Cell Assay
D004337:Drug Carriers; D015251:Epirubicin; D007459:Iodized Oil; D004317:Doxorubicin